Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PayPal, Moderna, TeleDoc, and 1000s of other stocks got hammered down just as much as $RVVTF the last 15 months.
Real DD Matters
"Yes its all MM and hedge fund backed shorts running down the SP of everything on the stock market" Yep....
I’m also heave in this maybe more than you. No choice except to hold.
Question for me is getting to 800.
Yeah they burned through their cash going other directions, also got blindsided by Omicron I think. I want to see high-risk study participants and that review at 800.
My worry is how they get the funding as most...or partner with JnJ etc :)
can they do that with 210 data show what Bmt u etc thinks.. Good Data.or what left from the 4.3 m or whatever to only get high rishk, lol. I mean chit they got 23m funding for trial which is about 70% done. so maybe they got 3m left to finish,,,not enough if you see 20m only got 70% of the trial done.
Ps. Holding because of the science and a few smart DD people :)
pps. lol can someone delete one of same post well damn this northern lights vape has me to realaxed
Exactly the issue I’m raising they don’t seem to have a clear strategy
Trip, us other Longs are all pissed too but please don't be THAT guy who sold everything on Monday and now lingers on here bashing it all. Based on your historic posts, you are classier than that I think.
Didn’t RVVTF initiate the request for an endpoint swap around a year ago and now they’re deciding to not do it? Hopefully they have a good path forward
Yes its all MM and shorts running down the SP of a pennystock with no revenue and a flailing phase III covid trial that they’ve tripled over themselves every step of the way. Can’t be that
Nonsense, big pharma has lost trillions of dollars in failed drug trials.
$RVVTF is still in the fight and 7 years closer to an approval on a record breaking phase III trial that the market has ever seen on a small start start up sized firm in this sector.
Hogwash, it is naked shorts and MM games that are the share price problem.
$RVVTF Bear traps are set now.
That’s just examples that rvv leadership is incompetent when it comes to bringing a new drug to market
Complete gibberish.
$RVVTF is still in the game.
No one is questioning the back and forth which is a positive
It’s all up to MF to make good decisions on how to spend the millions he raised 3x the pps today
He’s not very smart according to the pps and the staggering losses by many bag holders here
When your good let em know it, right?
Really? So fda said we want these endpoints and mf said nope we are good with the old ones? That doesn’t sound much like a back and forth to agree on endpoints. That is the fda saying we will accept these endpoints and mf, in all his brilliance, saying no I feel like screwing everyone and wasting the past year so I will stick with the old ones. I’m sure you will have an excuse for that as well. Just make sure you buy all the shares in the next dilution to fund the rest of the trial that has no patients. It takes some sort of idiot not to unblind a trial that you know you can’t finish. At this point he is just dragging this thing out. Unblind and sell based on the pcr data and maybe they can salvage a couple hundred mill.
Yes and the PR is a written response to the public regarding said written responses from the GDA where RVVTF said no thanks we will ignore and continue with previous end points which were already rejected by the FDA.
Hospitalizations and deaths are no longer a thing to 99%+ of the public with these weaker strains. Hence why FDA wants time to resolved symptoms.
Does this drug help people who get sick with covid get better faster yes or no? That’s it. Thats what the FDA wants to know. Not whether they will die.
The FDA is looking for essentially a stronger Dayquil for covid. Plain and simple.
Revive is ignoring that request apparently. Or the data doesn’t support it. That simple
As recently reported by the Company, the FDA has granted the Company’s Type C meeting request to obtain agreement on the revised protocol endpoints for the Company’s Phase 3 clinical trial (the “Study”) (NCT04504734) to evaluate the safety and efficacy of bucillamine, an oral drug with anti-inflammatory and antiviral properties, in patients with mild to moderate COVID-19. The goal date for the FDA to provide its written responses is March 7, 2023.
TYPE C Meeting..............When requesting a Type C meeting, Sponsors can request a written response to their questions rather than an in-person meeting, videoconference, or teleconference. A sponsor may request a face-to-face meeting, but the FDA may decide that only a written response is necessary.
Yes, written correspondence would equate to a "back and forth" between parties.
Some should learn to Read and Comprehend before posting laughably mindless comments. lololsss
LOL 20 cents?! This hasn’t seen 20 cents in six months. Now its going to .20 on this news?! Pump pump pump
The last boy scout is buying them all
It ain't over till the fat lady sings. The US Banks crashed and burned and this week rose from the dead like the Phoenix rising.
RVVTF is up 66% in 2 two days on heavy volume since the opening crash monday, market sell (likely MM shorts tripping fools stop loss orders) And the shares I bought the knife on a day ago are up 20% today.
This beast could be back at 20 cents in week.
Did you sell all your shares or have you held on to all / some, Trip?
I wouldnt mind grabbing some more,just dont have any cash left right now.
Lotto ticket buys
People here are buying. Maybe a lot now?
Sorting out the noise could be helping folks call their shots better.
Who is buying all these shares.
Half a million plus shares bought over the last hour or so. Nobody would buy at a nickel for no good reason. Gotta have hope!
MF raised 4.3mil at .15 valuation
He’s got cash how he will spend it is anyone’s guess
Most importantly, glad to see you're still around Gatorca. And congratulations on the cheapies.
Where there truly is BIG money to be made, there should surely be a big player wanting to make that money. My hope, is that deals are already being made between MF and whoever that may be and we all get to put RVVTF behind us with some profit to show for sticking around.
Many lessons learned these last three years. I'd like to put them in to practice.
I bought many in the .03 range well for me :) Rubber yesterday acutally average down .01 lol still over %50 down since under .10.
ps. yea im still alive, yesterday talked to ,Bluehorseshoe, Rio and even Ecomike
pps. Cw almost sure rio is still holding but even bored of the tweets.
ppps. my main worry like others im sure is can Mf get a partner with the 210 data.... otherwise how is he getting more money so this trial does not go another year to finish....to fund. and it is good to see this in the news...to develop a defined recruitment plan that prioritizes subjects recognized to be at higher risk for developing severe COVID-19 to achieve the Study’s objectives.
But without partner how is this not going to take until end of this year or so?
Ps.Im holding until whatever happens to much DD how good Bucillamine should work from Bmt,Ecomike ,Ninetendo64
pppps. glad I have couple days off damn this northern lights vape is very relaxing :)
I added some. I haven’t sold yet
I wish I had been able to buy in the .03's and sold today in the high .04's. Who wouldn't?
And there you have it. So called experts pumping at .15 still buying in the .03s
Don’t worry ric said he was buying all shares under a nickel
Yes a huge thanks for the huge donation (3s) today.......expecting an easy 3 - 5+ bagger in the coming weeks/month(s) from these levels.
Like I had mentioned several times before, ive essentially traded the same stock from the 08 crisis to this day so ignoring all the noise wasnt very difficult.
Learned a very valuable lesson from the last fin crisis and its aftermath about holding out for the ""BIG SCORE"" and have never looked back since.....once bitten, 1000X shy!!!
Has been interesting to watch all the various levels of ""meltdown"" over this mornings Pr....... of course the faux analysis from halfwits were entertaining as expected. lololsss
The only thing thats changed a bit is that my view towards rvv management, which includes the med team, is that I now believe they are inept.......as far as buccy goes, im sticking with the solid science.
@joebenson........wheres hotmeat???
A tad bit slow innit.............................
Hey Blue. I was wondering when you would chime in today. Gator and Gio, as stated by Rubber, are like me. They are stewing about the pps, the delays of unblinding the data and several dozen other things I can think of but don't care to list. It just a long term hold for me,but very likely about 7 more years at work than I intended. Unless a miracle appears from some big Pharm savior, all the other stuff is just too far away to get excited.
ps. Rio- If you read this, your posts were always informative. I'm curious if you moved on- I can't blame you.
pps. Here is my new blackjack analogy. We have a 16 and the dealer has an Ace. Maybe a long term covid possibility, but I can't even think right now. I keep telling myself it's just a paper loss. Ugh.
Ecomike…it’s over. You’re smart man.
Can I join the Ecomike bowling team as im not going anywhere,just holding.
EcoMike, I have 16 pound diamond balls and a 300 to my name.. these things take time and endured pressure to make......diamonds, 300's, and .......
As a ditch digger once told, we wait...
You bought his shares.
Got that right brother
Eco
I'm a bowler. Only use a 15.lb ball these days because of technology and expect the same from the RVVTF CEO!
I'm not blowing smoke up someone's proverbial and I sure am not in league with anyone, but I've watched naysayers dispute Ecomike's positive claims on a stock that seemed dead, and low and behold, if I'd had money to invest in that stock I would have enjoyed hefty gains.
For a newbie who has nothing left right now but hope in what seems like a shitty situation I'll trust the words of someone with a track record of being right when everyone else was wrong.
P. S. I hope Giovanni and Gatorca didn't top themselves today.
LOL now you pivot to the orphan drug status and shrooms? You have no shame.
Let me guess you saw this all coming?
Yes, and that was our hope with RLFTF too. But the big pharma buyout never happened. It's just a pipe dream IMO. But then again, stranger things have happened. There are investors on RLFTF that lost hundreds of thousands of dollars. And I'm sure that there are some here are sitting on those type of losses too. However, the insiders always win, and Michael Frank still gets his big fat salaries and bonuses. It is what it is.
Followers
|
337
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
36642
|
Created
|
02/23/17
|
Type
|
Free
|
Moderators Classic Warrior |
Scientific Rationale of Bucillamine
Preclinical and clinical studies have demonstrated that reactive oxygen species contribute to the destruction and programmed cell death of pulmonary epithelial cells.1 N-acetyl-cysteine (NAC) has been shown to significantly attenuate clinical symptoms in respiratory viral infections in animals and humans, primarily via donation of thiols to restore antioxidant and to reduce the activity of cellular glutathione 2,3,4,5. Bucillamine (N-(mercapto-2-methylpropionyl)-l-cysteine) has a well-known safety profile and is prescribed in the treatment of rheumatoid arthritis in Japan and South Korea for over 30 years. Bucillamine, a cysteine derivative with two thiol groups, has been shown to be 16 times more potent as a thiol donor in vivo than NAC 6. The drug is non-toxic with high cellular permeability. The basis of the clinical study will analyze if Bucillamine has the potential, via restoration of glutathione activity and other anti-inflammatory activity, to lessen the negative consequences of SARS-CoV2 infection in the lungs.
| Psilocin Pharma Corp. has developed production solutions for the active compound Psilocybin. Our process encompassed with our intellectual property cover methods of production of Psilocybin based formulations. Psilocin Pharma Corp’s range of products have been engineered to work synergistically with the body's own natural pathways of absorption while offering a contemporary approach to consumption. Psilocin Pharma also has strong relationships with specific lab partners in certain areas like Brazil, where these formulations are legally approved and plan to sell products in these jurisdictions. | |
| |
Mental Health (Depression, PTSD & Anxiety)
|
Supplements for Brain Health & Cognitive Enhancement
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |